This inventor holds 1 USPTO granted patent. Top assignee: Suvalent Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Miles Kubota: Innovator in Cancer Treatment
Introduction
Miles Kubota is an accomplished inventor based in Monrovia, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.
Latest Patents
Miles Kubota holds a patent for "Sumo inhibitor compounds and uses thereof." This invention relates to compounds and compositions capable of acting as inhibitors of the small ubiquitin-like modifier (SUMO) family of proteins. The compounds and compositions developed by Kubota may be utilized in the treatment of cancer. His patent also discloses methods for inhibiting an E1 enzyme, along with compounds that are effective in this inhibition.
Career Highlights
Miles Kubota is currently associated with Suvalent Therapeutics, Inc., where he continues to advance his research in the field of oncology. His work focuses on developing innovative therapeutic solutions that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Xiaohu Ouyang and Ted Charles Judd, who collaborate with him in his research endeavors.
Conclusion
Miles Kubota's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the field of medical research. His work continues to pave the way for advancements in therapeutic strategies against cancer.